TrademarkDir
TAURPACK
LIVE

Serial Number

79247928

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 1, 2018

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TAURPACK Trademark

Serial Number: 79247928 • Registration: 6522541

TAURPACK is a trademark filed by Novartis AG on November 1, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

November 1, 2018

Registration Date

October 19, 2021

Published for Opposition

August 3, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

IRREGULARITY ON FINAL DECISION RECEIVED FROM IB
Mar 13, 2026 IRFI
GENERIC MADRID TRANSACTION SENT TO IB
Mar 30, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 30, 2022 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 19, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 19, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Aug 7, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 3, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 3, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 14, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 14, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 14, 2021 NONP
NOTICE OF REINSTATEMENT E-MAILED
Jul 2, 2021 MREI
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Jul 1, 2021 CORR
REINSTATED
Jun 29, 2021 REIN
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 25, 2020 CRCV
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
May 30, 2019 DENA
DEATH OF INTERNATIONAL REGISTRATION
May 29, 2019 DETH
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2019 NPUB
PUBLISHED FOR OPPOSITION
Apr 2, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 21, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2019 CRFA
ASSIGNED TO LIE
Feb 18, 2019 ALIE
REFUSAL PROCESSED BY IB
Feb 15, 2019 RFNT
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 12, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 5, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 5, 2019 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 18, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jan 18, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 8, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jan 7, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 4, 2019 MAFR
ASSIGNED TO EXAMINER
Dec 31, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 31, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 27, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 20, 2018 SDRC

Related Trademarks

More from this Owner

NOVARTIS RLT NOW logo

NOVARTIS RLT NOW

NOVARTIS RLT NOW

NOVARTIS RLT NOW

TIVELGO

TIVELGO

NOVARTIS NOVARTIS logo

NOVARTIS NOVARTIS

Trademark logo

Serial #99735720

VODELPA

VODELPA